相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
Alexander Ambinder et al.
BLOOD ADVANCES (2022)
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia
Charles Craddock et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide
Benedetta Rambaldi et al.
BLOOD ADVANCES (2021)
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
Nelli Bejanyan et al.
BLOOD ADVANCES (2021)
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Mahasweta Gooptu et al.
BLOOD (2021)
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
Mohamed A. Kharfan-Dabaja et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
Bart L. Scott et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Giorgia Battipaglia et al.
CANCER (2021)
T cell regeneration after immunological injury
Enrico Velardi et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD
Bruce R. Blazar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation
Monzr M. Al Malki et al.
BLOOD ADVANCES (2020)
Comparative Efficacy and Clinical Outcomes of Haploidentical Stem Cell Transplantation to Other Stem Sources for Treatment in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis
Chutima Kunacheewa et al.
CELL TRANSPLANTATION (2020)
Personalized Chimerism Test that Uses Selection of Short Tandem Repeat or Quantitative PCR Depending on Patient's Chimerism Status
Jennifer Tyler et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
Giorgia Battipaglia et al.
BLOOD (2019)
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission
Armin Rashidi et al.
BLOOD ADVANCES (2019)
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
Christelle Retière et al.
Oncotarget (2018)
Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained
Lauren E. Caldemeyer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT
Courtney D. Fitzhugh et al.
BLOOD ADVANCES (2017)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Early lymphocyte recovery predicts superior outcomes after unmanipulated haploidentical blood and marrow transplant for acute myeloid leukemia
Qiang Fu et al.
CLINICAL TRANSPLANTATION (2016)
Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults
Pierre Peterlin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Shernan G. Holtan et al.
BLOOD (2015)
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
J. Peccatori et al.
LEUKEMIA (2015)
Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
Ran Reshef et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Clinical impact of absolute lymphocyte count on day 30 after unmanipulated haploidentical blood and marrow transplantation for pediatric patients with hematological malignancies
Ying-Jun Chang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
Katarina Le Blanc et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells
J. J. A. Coenen et al.
BONE MARROW TRANSPLANTATION (2007)
分享论文
